Koers Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Aandelen
RMDA
EGS381B1C015
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,19 EGP | +6,83% | +10,61% | +32,73% |
Omzet 2024 * | 2,92 mld. 62,61 mln. 57,59 mln. | Omzet 2025 * | 3,53 mld. 75,82 mln. 69,73 mln. | Marktkapitalisatie | 3,26 mld. 70,05 mln. 64,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 388 mln. 8,33 mln. 7,66 mln. | Nettowinst (verlies) 2025 * | 534 mln. 11,46 mln. 10,54 mln. | EV/omzet 2024 * | 1,48 x |
Nettoschuld 2024 * | 1,07 mld. 22,89 mln. 21,05 mln. | Nettoschuld 2025 * | 766 mln. 16,44 mln. 15,12 mln. | EV/omzet 2025 * | 1,14 x |
K/w-verhouding 2024 * |
7,37
x | K/w-verhouding 2025 * |
5,63
x | Werknemers | - |
Dividendrendement 2024 * |
4,84% | Dividendrendement 2025 * |
8,04% | Vrij verhandelbaar | 50,28% |
1 dag | +6,83% | ||
1 week | +10,61% | ||
Lopende maand | +6,31% | ||
1 maand | -12,05% | ||
3 maanden | -15,77% | ||
6 maanden | +44,08% | ||
Lopend jaar | +32,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 01-01-11 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 01-01-19 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 01-01-20 |
Director/Board Member | 65 | 01-01-19 | |
Director/Board Member | - | 01-01-11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-05-24 | 2,19 | +6,83% | 7 924 592 |
16-05-24 | 2,05 | +3,54% | 7 047 411 |
15-05-24 | 1,98 | -0,50% | 3 123 296 |
14-05-24 | 1,99 | 0,00% | 1 961 645 |
13-05-24 | 1,99 | +0,51% | 3 385 068 |
slotkoers Egyptian Exchange, 19 mei 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,73% | 69,59 mln. | |
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+13,81% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |